SOURCE: Redux Holdings, Inc.

January 18, 2007 08:35 ET

Redux Holdings Completes Acquisition of Equity Interest in Koloseum Nutritional Sciences, Inc.

LOS ANGELES, CA -- (MARKET WIRE) -- January 18, 2007 -- Redux Holdings, Inc. (PINKSHEETS: RDXH) today announced that it has successfully completed the acquisition of a thirty percent equity interest in Koloseum Nutritional Sciences, Inc. in exchange for common stock in Redux Holdings.

Koloseum Nutritional Sciences, Inc. (KNS) is a new sports nutrition company that will market, sell and distribute innovative, science-driven performance nutrition supplements within the health and fitness channels. KNS has created a unique platform of hyper-anabolic and anti-proteolytic formulations designed to deliver optimum levels of nutrition to high performance athletes at the critical stages of exercise. Marketing efforts will focus on the consumer group identified as professional athletes, performance athletes, heavy users and regular users of sports nutrition and physique-modifying supplements. This retail market segment represented approximately $15.7 billion in 2004, as reported by Nutrition Business Journal.

Adam Michelin, CEO and Chairman of Redux Holdings, stated, "I am pleased to announce today's partnership with Koloseum Nutritional Sciences. I am confident that this partnership will create an abundance of synergistic opportunities across the portfolio of Redux Holdings, both at the retail level and with our supply chain partners."

Rick Robinette will serve as CEO of Koloseum Nutritional Sciences. Mr. Robinette has over 20 years' experience in executive leadership, operations, sales and marketing in the nutritional supplements industry. "I look forward to the tremendous opportunity to partner with Redux Holdings. The combined talent and relationships will create an optimum environment for building a world class sports nutrition supplement company," said Mr. Robinette.

Milos Sarcev will serve as President of Koloseum Nutritional Sciences. Mr. Sarcev, 1989 Mr. Universe, is a world recognized IFBB professional bodybuilding legend (, and personal trainer to professional athletes worldwide. "I am excited about the involvement of Redux with KNS and look forward to the opportunity to work with Adam Michelin to maximize the Koloseum brands," said Mr. Sarcev.

Koloseum Nutritional Sciences has developed a full line of sports nutrition supplements designed to meet the specialized nutritional needs of the high performance athlete. Their brand Imperium™ is a unique proprietary blend designed to create a "hyper-anabolic" state in pre, during and post workout activities. Their brand Protomax™ Protein Essentials is an ultra-high quality protein supplement that provides all essential nutrients, including omegas. KNS is also developing a lineup of solid dosage supplements for essential nutrients, vitamins and minerals, hormone amplification and weight management.

About Koloseum Nutritional Science, Inc.

Founded in 2006, Koloseum Nutritional Science's products will be sold in the health food channel, sports clubs, internet, and traditional retail stores (

About Redux Holdings, Inc.

Redux Holdings acquires the assets of companies and isolates, recombines and manages those assets to increase their value and develop profitable strategic options. The Company is distinguished by the extensive experience of its management in quickly identifying, analyzing and stabilizing these business opportunities and effecting rapid turnaround and asset monetization.

For additional information on Redux Holdings, Inc., visit the company's website at Investor information, including an investor fact sheet, is available for download at


This press release may contain forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact Information

  • Contact:
    Investor Relations:
    First Capital Investors, Inc.
    Trey Meehan
    Email Contact